June 24, 2025 10:57 AM EDT
News Briefing

Ar­riVent plots next steps for lung can­cer drug; Neu­ron23's $96.5M raise

ENDPOINTS

Plus, news about Rivus, Amarin, Recor­dati, Liq­uidia, Health­care Roy­al­ty, Lex­eo, Per­cep­tive, ven­Bio, No­vo Nordisk and Cidara:

Ar­riVent to start an­oth­er Phase 3 of lung can­cer …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ex­clu­sive: FDA's Makary sought re­jec­tion of KalVista’s drug in an un­usu­al move by com­mis­sion­er, sources say

RFK Jr. says he did not com­mit to up­hold­ing ACIP ros­ter to se­cure Cas­sidy’s back­ing

RFK Jr. pledges to keep the US at the cen­ter of the biotech 'rev­o­lu­tion'

For­mer FDA sci­en­tist and psy­che­delics re­searcher hired as CDER deputy di­rec­tor

Nek­tar's mid-stage eczema da­ta de­liv­er key win in bid for com­pa­ny turn­around

sponsored

Dig­i­tal Twins in GMP Man­u­fac­tur­ing: Shap­ing the Fu­ture of CPV with Aizon

A service from the Financial Times